PP
ACOR

PDT Partners’s Acorda Therapeutics ACOR Stock Holding History

PDT Partners’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-347
Closed -$649K – 516
2018
Q4 		$649K Sell
347
-139
-29% -$302K 0.04% 305
2018
Q3 		$1.15M Buy
+486
New +$1.5M 0.05% 296
2015
Q4 		– Sell
-318
Closed -$1.01M – 1039
2015
Q3 		$1.01M Buy
+318
New +$1.23M 0.02% 715
2015
Q2 		– Sell
-1,163
Closed -$4.65M – 1716
2015
Q1 		$4.65M Buy
1,163
+778
+202% +$3.56M 0.12% 213
2014
Q4 		$1.89M Sell
385
-208
-35% -$893K 0.18% 123
2014
Q3 		$2.41M Buy
593
+274
+86% +$1.03M 0.06% 359
2014
Q2 		$1.29M Buy
319
+22
+7% +$89.7K 0.03% 605
2014
Q1 		$1.35M Sell
297
-242
-45% -$978K 0.03% 592
2013
Q4 		$1.89M Buy
539
+88
+20% +$343K 0.23% 106
2013
Q3 		$1.85M Sell
451
-87
-16% -$375K 0.05% 518
2013
Q2 		$2.13M Buy
+538
New +$2.22M 0.05% 527

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PDT Partners's ACOR Position: Q1 2019 in Review

PDT Partners sold out of Acorda Therapeutics (ACOR) in Q1 2019, closing a stake of 347 shares — an estimated $649K sold.

PDT Partners first reported a position in ACOR in Q2 2013 and held it in 11 quarters. The position peaked at $4.65M in Q1 2015. 184 funds tracked by Wall St. Rank hold ACOR as of Q1 2019.

  • PDT Partners reported no remaining Acorda Therapeutics position as of Q1 2019 after selling out during the quarter.
  • PDT Partners sold 347 Acorda Therapeutics shares in Q1 2019, an estimated $649K.
  • PDT Partners first reported a position in Acorda Therapeutics in Q2 2013 and held it in 11 quarters.
  • PDT Partners's Acorda Therapeutics position peaked at $4.65M in Q1 2015.
  • 184 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2019.

Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.